The Levels of MDM2 Protein Are Decreased by a Proteasome-Mediated Proteolysis Prior to Caspase-3-Dependent pRb and PARP Cleavages.
10.3346/jkms.2001.16.2.135
- Author:
Jae We CHO
1
;
Jong Chun PARK
;
Je Chul LEE
;
Taeg Kyu KWON
;
Jong Wook PARK
;
Won Ki BAEK
;
Seong Il SUH
;
Min Ho SUH
Author Information
1. Department of Microbiology, College of Medicine, Seonam University, Namwon, Korea. jwcho@tiger.seonam.ac.kr
- Publication Type:Original Article
- Keywords:
HL-60 Cells;
Ubiquitin;
Apoptosis
- MeSH:
Antineoplastic Agents, Phytogenic/pharmacology;
Apoptosis/drug effects/physiology;
Caspases/*metabolism;
Cysteine Endopeptidases/*metabolism;
Down-Regulation (Physiology)/physiology;
Etoposide/pharmacology;
HL-60 Cells;
Human;
Multienzyme Complexes/*metabolism;
NAD+ ADP-Ribosyltransferase/*metabolism;
Proto-Oncogene Proteins/*metabolism;
Retinoblastoma Protein/*metabolism
- From:Journal of Korean Medical Science
2001;16(2):135-139
- CountryRepublic of Korea
- Language:English
-
Abstract:
MDM2 is a substrate of caspase-3 in p53-mediated apoptosis. In addition, MDM2 mediates its own ubiquitination in a RING finger-dependent manner. Thus, we investigated whether MDM2 is degraded through a ubiquitin-dependent proteasome pathway in the absence of p53. When HL-60 cells, p53 null, were treated with etoposide, MDM2 was markedly decreased prior to caspase-3-dependent retinoblastoma tumor suppressor protein (pRb) and poly (ADP- ribose) polymerase (PARP) cleavages. Moreover, down-regulation of MDM2 level was not coupled with its mRNA down-regulation. However, the level of MDM2 was partially restored by proteasome inhibitors such as LLnL and lactacystin, even in the presence of etoposide. Our results suggest that, in the p53 null status, MDM2 protein level is decreased by proteasome-mediated proteolysis prior to caspase-3-dependent PARP and pRb cleavages.
